| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6068385 | The Journal of Allergy and Clinical Immunology: In Practice | 2015 | 10 Pages |
Abstract
Children with mild persistent asthma who have markers of atopic asthma or who have greater asthma burden may obtain greater benefit from beclomethasone therapy. Additional study is needed to confirm whether these markers can guide individualized therapy.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Joe K. MD, PhD, Lynn B. PhD, MSPH, Monica M. MPH, MEd, Wayne J. MD, Susan J. MA, Robert F. MD, David T. PhD, Robert C. MD, Stanley J. MD, Robert S. MD, Leonard B. MD, Elizabeth MD, Ronina A. MD, Theresa W. MD, Hengameh PharmD, H. William PharmD,